Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1278 Carcinoma, Non-Small-Cell Lung 927 Prostatic Neoplasms 729 Neoplasms 633 Multiple Myeloma 554 Lymphoma 540 Colorectal Neoplasms 530 Lung Neoplasms 515 Leukemia 498 Leukemia, Myeloid, Acute 474 Neoplasm Metastasis 471 Melanoma 426 Lymphoma, Non-Hodgkin 420 Ovarian Neoplasms 417 Leukemia, Lymphocytic, Chronic, B-Cell 386 Pancreatic Neoplasms 373 Recurrence 338 Precursor Cell Lymphoblastic Leukemia-Lymphoma 329 Head and Neck Neoplasms 307 Lymphoma, Large B-Cell, Diffuse 295 Glioblastoma 294 Myelodysplastic Syndromes 288 Lymphoma, Follicular 287 Brain Neoplasms 287 Stomach Neoplasms 282 Carcinoma, Renal Cell 268 Carcinoma, Hepatocellular 262 Hodgkin Disease 261 Rectal Neoplasms 256 Sarcoma 250

Interventions

pegylated granulocyte colony-stimulating factor, human 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Completed × Chemotherapy Induced Neutropenia × Clear all

NCT01923545 2014-10-01

PEG-G-CSF

Dong-A ST Co., Ltd.

Phase 2 Completed

Chemotherapy Induced Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡